AtaCor - Model EV - Implantable Temporary Pacing Cardiac System
First of its kind, the innovative AtaCor EV Temporary Pacing System is advancing the standard of cardiac pacing. It is the only implantable temporary pacing system designed to leave the heart and vascular system completely untouched—for prompt pacing support without the discomfort, risk, and limitations of traditional methods.
Product Details
Using a proprietary parasternal approach, the AtaCor EV Temporary Pacing System advances a custom pacing lead into the extracardiac tissue between the ribs and pericardium.
By harnessing the human anatomy, the AtaCor EV Temporary Pacing System is engineered to provide reliable pacing support while eliminating the risks and complexity of transvenous pacing.
TEMPORARY PACING BEYOND THECATH LAB–AND BEYO...
TEMPORARY PACING BEYOND THECATH LAB–AND BEYOND EXPECTATIONS.
In addition to streamlining delivery of temporary pacing, the AtaCor EV Temporary Pacing System’s extravascular implantation is designed to remove bedrest restrictions, speeding patient recovery and shortening hospital length-of-stay:
- Supports safe post-procedure patient ambulation
- Enables patient transfer to non-ICU bed for extended evaluation
- Reduces need for ICU observation and related nursing resources, decreasing cost-of-care
TAVR procedures are on the rise—and expected to increase as the population ages and procedure indications expand to younger and healthier patients.1 The AtaCor EV Temporary Pacing System is designed to support stable extravascular and extracardiac pacing during valve deployment and postoperative evaluation for conduction disturbances, for streamlined TAVR patient management and recovery:
- Enables preoperative lead insertion which may shorten overall procedure length
- Connects to commercially-available external temporary pacemakers
- Eliminates transvenous pacing leads
- Reduces vascular access management and complications
- Enables safe post-procedure patient ambulation
- Eliminates bedrest restrictions, reducing ICU and related nursing costs
Conduction abnormalities, whether transitory or persistent, develop in approximately 90% of patients who experience a myocardial infarction.2 The AtaCor EV Temporary Pacing System is designed to support stable pacing of new-onset arrhythmias to help guide treatment decisions and optimize patient care:
- Enables evaluation of conduction disturbances to determine the need for permanent pacing
- Enables safe post-procedure patient ambulation
- Eliminates bedrest restrictions, reducing ICU and related nursing costs
Customer reviews
No reviews were found for AtaCor - Model EV - Implantable Temporary Pacing Cardiac System. Be the first to review!